Lawmakers in the House are kicking off an investigation of Allergan's tribal licensing deal to protect Restasis.
Allergan is again being accused of using unfair tactics to dodge competition for its eye drug Restasis, this time for using bundled contracts.
Clinical care experts and patient advocacy organizations call attention to why better patient understanding shapes the best integrated approach to orphan drug…
Alleging deception against shareholders by biotech Altor, music icon Cher is suing billionaire Patrick Soon-Shiong and others at the drug developer.
The generic drug industry's effort for relief against Maryland pricing regulations has come up short, at least for now.
Brought to you by the publisher of FierceBiotech and FiercePharma, the Fierce Innovation Awards Life Sciences Edition identify and showcase outstanding…
Rep. Elijah Cummings, D-Md., is urging President Trump to press for lower prices on Biogen's multiple sclerosis drug Zinbryta.
It didn't take long for Congress to push back at Allergan's first-of-a-kind patent deal with the Saint Regis Mohawk Tribe.
In a temporary break from its corporate drama, Sinovac posted positive topline data from a phase 3 study of its chickenpox vaccine.
A lawsuit alleges J&J has "blatantly lied" for decades about talc safety, accusing the company of participating in a conspiracy to conceal the…
Aegerion Pharmaceuticals will shell out $35 million to resolve claims that it marketed Juxtapid for use beyond its FDA approval.
Johnson & Johnson is not going down without a fight after suffering a stinging $417 million talc powder defeat last month.